I had a job interview last week, it was for good money. However, it was clear that my main duty would be to ensure "medication compliance". I didn't take the job. I am a professional and as such my first duty is to my clients. I hope this info may help someone who needs it. Also, you can google the National Empowerment Center. After all, it is your life.

AlterNet / By Bruce E. Levine 23 COMMENTS
Some Psychiatrists Distancing Themselves from Profession as Drug Company Dominance Makes Some Shrinks Very Rich, and Many Patients Over Drugged
Psychiatry has a real credibility problem on its hands.
April 15, 2014 |
What does it tell us about the state of psychiatry when some of the biggest names in the psychiatric establishment are distancing themselves from psychiatry’s diagnostic system and its treatments?

In 2013, National Institute Mental Health director Thomas Insel, citing the lack of scientific validity of psychiatry’s official diagnostic manual, the DSM, stated that, “NIMH will be re-orienting its research away from DSM categories.” In response, Robert Whitaker, investigative reporter and author of Anatomy of an Epidemic, observed, “This is like the King of Psychiatry saying that the discipline has no clothes.”

“When Insel states that the disorders haven’t been validated,” Whitaker points out, “he is stating that the entire edifice that modern psychiatry is built upon is flawed, and unsupported by science... If the public loses faith in the DSM, and comes to see it as unscientific, then psychiatry has a real credibility problem on its hands.”

Other establishment psychiatrists are also distancing themselves from psychiatry’s diagnostic manual. Psychiatrist Allen Frances, the former chair of the DSM-4 task force, now writes about how the DSM is a money machine for drug companies (“ Last Plea To DSM-5: Save Grief From the Drug Companies”).

Frances, emeritus professor of psychiatry at Duke University, was until recently among the most inside of insider psychiatrists. However, in an April 11, 2014 New York Times article about “sluggish cognitive tempo,” which would add 2 million more children to the already 6 million diagnosed with attention deficit hyperactivity disorder, Frances stated, “Just as ADHD has been the diagnosis du jour for 15 years or so, this is the beginning of another. This is a public health experiment on millions of kids.”

That’s the kind of language that once so marginalized mental health professionals critical of establishment psychiatry that we were not quoted in the New York Times or any other mainstream media.

NIMH director Insel has also increasingly been distancing himself from standard psychiatry drug treatments. In 2009, Insel wrote: “For too many people, antipsychotics and antidepressants are not effective, and even when they are helpful, they reduce symptoms without eliciting recovery.”

The sad fact is that treatment-resistant depression is increasing, and there is a great deal of evidence that the reason is long-term use of antidepressants. A review of the research in 2011 in the journal Medical Hypotheses concluded: “Depressed patients who ultimately become treatment resistant frequently have had a positive initial response to antidepressants and invariably have received these agents for prolonged time periods at high doses.”

In 2013, Insel announced that the latest research shows that psychiatry’s standard drug treatment for people diagnosed with schizophrenia and other psychoses needs to change. In February 2014, the New York Times published a feature story on Insel, noting that his questioning the long-term use of antipsychotics caused a major stir in psychiatry.

But while politically astute establishment psychiatrists such as Insel, Frances and others are calling for reform, the institution of psychiatry may well be so damaged by a generation of drug company corruption that it cannot be reformed in any meaningful way.

Too Corrupt

The DSM is published by the American Psychiatric Association, and according to the journal PLOS Medicine, “69% of the DSM-5 task force members report having ties to the pharmaceutical industry.” The corruption of the APA by Big Pharma is nothing new. In 2008, the New York Times reported the following about APA: “In 2006, the latest year for which numbers are available, the drug industry accounted for about 30 percent of the association's $62.5 million in financing.”

Were they drugged?

LOL, yes by Big Pharma money

I have always felt that in MOST instances depression, attention deficit, and some personality disorders were more directly related to behavior modifcation or other environmental factors, and that being the only way to permanently affect a change, drugs at best postpone what actually needs to happen ...kinda like an overweight diabetic who shoots more and more insulin rather than losing weight and exercising. So drug therapy actually can inhibit positive changes that need to happen. Not all people can "self manage" with a little help, but I believe more can than not. The individual must want the changes or they will not happen...even with drugs.

The human mind is a powerful tool that we too often forget to utilize.

interesting article TB